调节性T细胞在富含氨的瘤中壮成长
Chenxian Ye1, Greg M Delgoffe1
1Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Cell metabolism
|March 4, 2026
概括
调节性T (Treg) 细胞使用瘤氨来抑制免疫力. 抑制瘤谷氨胺代谢减少氨,并提高抗PD-1癌症治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 调节性T (Treg) 细胞对于免疫平衡至关重要,但也可以抑制抗瘤免疫力.
- 瘤微环境经常表现出改变的代谢状态,包括高氨水平.
- 对抗PD-1治疗等免疫检查点抑制剂的耐药性仍然是一个重大的临床挑战.
研究的目的:
- 研究Treg细胞在瘤微环境中促进免疫抑制的代谢机制.
- 探索瘤衍生的氨在Treg细胞功能和治疗耐药性的作用.
- 确定潜在的代谢标,以克服抗PD-1治疗的耐药性.
主要方法:
- 在瘤载体模型中分析Treg细胞代谢.
- 测量氨含量和代谢流量.
- 研究Treg细胞中的尿素循环和精氨酸合成途径.
- 对依赖PPARγ的氧化酸化的评估.
- 对瘤谷氨胺代谢抑制的评估.
- 测试联合代谢抑制和抗PD-1疗法的疗效.
主要成果:
- Treg细胞通过尿素循环和精氨合成代谢瘤衍生的氨.
- 这种代谢过程通过PPARγ依赖的氧化酸化促进免疫抑制.
- 抑制瘤谷氨胺代谢有效降低氨水平.
- 降低氨水平克服了Treg细胞介导的抗PD-1治疗的抵抗力.
结论:
- 由Treg细胞的瘤衍生的氨代谢是免疫抑制的关键机制.
- 向瘤谷氨胺代谢是一种可行的策略,可以增强抗PD-1免疫疗法.
- 代谢干预措施有望克服癌症治疗耐药性的可能性.
更多相关视频
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
10.4K
07:36Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.8K
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
